Navigation Links
Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
Date:12/4/2007

t program evaluating the efficacy and safety of this novel biologic in the treatment of moderate to severe plaque psoriasis," said Jerome A. Boscia, M.D., senior vice president, Clinical R&D, Centocor, Inc. "We remain committed to developing safe and effective new therapies for patients with inflammatory diseases like psoriasis through continued research and development in disease areas where unmet needs in treatment remain."

About Psoriasis

Psoriasis is a chronic, immune-mediated disease, which results from the overproduction of skin cells resulting in their accumulation on the surface of the skin, which causes red, scaly plaques that may itch and bleed. It is estimated that approximately 7.5 million people in the United States and 10 million Europeans are living with psoriasis and nearly one-quarter of those people have cases that are considered moderate to severe.(1)

About Ustekinumab

Ustekinumab is a new, human monoclonal antibody in Phase 3 development by Centocor, Inc. for the treatment of moderate to severe plaque psoriasis, and is being investigated as an infrequently administered subcutaneous injection. Ustekinumab is a novel biologic therapy that targets interleukin 12 (IL-12) and interleukin 23 (IL-23), naturally occurring proteins that are important in regulating the immune system and that are also believed to play a role in immune-mediated inflammatory disorders.

Centocor discovered ustekinumab and has exclusive marketing rights to the product in the United States. Janssen-Cilag companies have exclusive marketing rights in all countries outside of the United States. Centocor, Inc. and the Janssen-Cilag companies are members of the Johnson & Johnson family of companies.

About Centocor, Inc.

Centocor is harnessing the power of world-leading research and biomanufacturing to deliver innovative biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's dise
'/>"/>

SOURCE Centocor, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CLIA Waiver Submitted for Rapid HIV Test Employs StatSures Barrel Technology
2. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
3. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
4. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
5. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
6. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
7. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
8. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
9. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
10. CryoCor Receives FDA Approval for Right Atrial Flutter
11. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... BGI gab heute bekannt, dass ... American College of Pathologists (CAP) akkreditiert wurde. ... klinische Next-Generation-Sequencing Labor, das in ... somit die höchsten Standards an klinischer Laborpraxis ... - 21 CFR Part 11 konformen Laborverfahren ...
(Date:7/2/2015)... , July 2, 2015  AbbVie (NYSE: ... on Friday, July 24, 2015, before the market opens. ... the earnings conference call at 8 a.m. Central time ... Investor Relations website at www.abbvieinvestor.com . An archived ... a.m. Central time. About AbbVie ...
(Date:7/2/2015)... June 25, 2015 Research ... the "Veterinary / Animal Vaccines Market by Product, ... report to their offering. The global animal ... 2020 from $5,507.3 Million in 2015, at a CAGR ... factors fueling market growth are growing prevalence of animal ...
Breaking Medicine Technology:BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2
... 2011 BD Biosciences, a segment of BD (Becton, ... new BD Falcon™ Multi-Flask, a multi-layer cell culture device ... easily and more efficiently. Currently, most ... new BD Falcon Multi-Flask, available in both three- and ...
... Thousands of jobs in Texas supported by the biopharmaceutical ... such as imposing new taxes in the Medicare prescription ... From research to technical work, manufacturing to construction ... services, the biopharmaceutical sector supports a broad array of ...
Cached Medicine Technology:BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity 2Research Demonstrates Possible Texas Job Losses from Sectors Supported by Biopharmaceutical Companies 2Research Demonstrates Possible Texas Job Losses from Sectors Supported by Biopharmaceutical Companies 3
(Date:7/3/2015)... , ... July 03, 2015 , ... Renowned rhinoplasty ... dates for the 2016 Dallas Rhinoplasty Symposium . To be held from March ... meeting will be held at the Westin Galleria Dallas. , Designed to take participants ...
(Date:7/3/2015)... ... July 03, 2015 , ... Talcum powder attorneys representing clients in national lawsuits ... Cancer Lawsuit Center website. Just as the previous version did, the new website will ... lawsuit updates and ovarian cancer warning information. The site is routinely updated with news ...
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness and the Red ... of the Red Deer community with free fitness training and indoor fitness boot camp ... events and entertainment raised thousands of charity dollars and ended with a $10,000 donation ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on ... Samir Becic emphatically declared a war on obesity in the United States. , "Obesity ... must understand the magnitude of this discovery. For that reason, I am declaring, along ...
(Date:7/2/2015)... ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift of poetry was ... down to write his first poem, and three years later he was publishing an entire ... worth sharing with the world. "I have always believed that the best way to lift ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2
... is a whole lot of truth in saying that the ... much or too less of anything is bad for health//. ... Medicine researchers, commenting upon Optimum Sleep requirement, say that Men ... victims of Type 2 diabetes. ,The statistics printed ...
... Millán’s, an agricultural engineer has developed a technique which ... Human serum albumin (HSA) from tobacco plants. HSA is ... for therapeutic needs. ,It is mainly used ... heart attacks. It is used for haemorrhages, burns, surgical ...
... will now work for birth control in all the schools ... of teenage pregnancies//. ,There are currently 2,409 nurses who ... the latest announcement signals a massive extension, reported the online ... care trust will be funded to have at least one ...
... of Veterinary Medicine have established a national surveillance ... humans and animals using medical records of pets. ... of Epidemiology. Larry Glickman of the School of ... Hospital, a nationwide chain of veterinary hospitals to ...
... - The WHO has revealed that Africa's TB crisis has ... show that//, of the two million people who die from ... Nzioka, a nurse at the African Medical and Research Foundation ... the patients who succumbed to TB were also infected with ...
... System say the federal government could promote flu vaccination to ... lives. They suggest that if the Federal government were to ... the lines of pharmaceutical companies. , ,They are hoping ... are at a higher risk of death due to influenza ...
Cached Medicine News:Health News:Alternate ways to produce HAS from tobacco plants 2Health News:Pets As Disease Watchdogs 2Health News:Influenza Vaccination For The Elderly 2
... Riata i lead family ... versatility when managing patients ... (DFTs)., The new Riata ... physicians even more versatility ...
... Millennium™ microsurgical system delivers on the ... technology. For the latest advancement in ... Bausch & Lomb Surgical offers CONCENTRIX™ ... pump to provide both flow and ...
... Microscope with excellent maneuverability. Konan ... weight maintaining high quality. Easy ... by simply changing the adapter. ... has resulted in a sharp ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
Medicine Products: